<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">18565510</PMID><DateCompleted><Year>2008</Year><Month>10</Month><Day>24</Day></DateCompleted><DateRevised><Year>2021</Year><Month>10</Month><Day>20</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">0014-2999</ISSN><JournalIssue CitedMedium="Print"><Volume>589</Volume><Issue>1-3</Issue><PubDate><Year>2008</Year><Month>Jul</Month><Day>28</Day></PubDate></JournalIssue><Title>European journal of pharmacology</Title><ISOAbbreviation>Eur J Pharmacol</ISOAbbreviation></Journal><ArticleTitle>Differential effects of triptolide and tetrandrine on activation of COX-2, NF-kappaB, and AP-1 and virus production in dengue virus-infected human lung cells.</ArticleTitle><Pagination><StartPage>288</StartPage><EndPage>298</EndPage><MedlinePgn>288-98</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ejphar.2008.04.056</ELocationID><Abstract><AbstractText>Most virus infections induce cycloxygenase-2 (COX-2) expression and subsequent prostaglandin E(2) (PGE(2)) production in cells, an inflammatory response that might be detrimental to virus replication and pathogenesis. This response in dengue virus infection remains to be elucidated. Triptolide and tetrandrine, compounds derived from two commonly used Chinese herbs, both demonstrate anti-inflammatory and immunosuppressive effects partly through modulation of COX-2 expression and, hence, may have antiviral effects. In this study, we examined, firstly, the immune response to dengue virus infection with respect to COX-2 expression and PGE(2) production in human lung cells (A549), liver cells (HepG2) and dendritic cells. Secondly, we assessed the potential antiviral effects of triptolide and tetrandrine on dengue virus infection vis-&#xe0;-vis expression of COX-2, PGE(2), transcription factors, as well as virus production. We found that dengue virus infection enhanced COX-2 expression and PGE(2) production in A549 cells, similarly to the response in dendritic cells, but not in HepG2 cells. In dengue virus-infected A549 cells, nuclear factor kappaB (NF-kappaB) and activator protein 1 (AP-1) were also activated, and both were dose-dependently inhibited by triptolide (0.5-4 ng/ml). Tetrandrine (1-10 microM) had no similar immunosuppressive effects and, moreover, at higher concentrations, enhanced NF-kappaB and AP-1 activity, COX-2 expression and PGE(2) production. However, unexpectedly, tetrandrine, but not triptolide, dose-dependently suppressed dengue virus production in A549 cells, independent of PGE(2) level. Our findings imply that triptolide and tetrandrine may attenuate dengue virus infection in human lung cells, but through distinct pathways.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Liou</LastName><ForeName>Jun-Ting</ForeName><Initials>JT</Initials><AffiliationInfo><Affiliation>Division of Cardiology, Department of Medicine, Tri-Service General Hospital, School of Medicine, National Defense Medical Center, Taipei, Taiwan, ROC. ljtmail@gmail.com &lt;ljtmail@gmail.com&gt;</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Zih-Yan</ForeName><Initials>ZY</Initials></Author><Author ValidYN="Y"><LastName>Ho</LastName><ForeName>Ling-Jun</ForeName><Initials>LJ</Initials></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Shih-Ping</ForeName><Initials>SP</Initials></Author><Author ValidYN="Y"><LastName>Chang</LastName><ForeName>Deh-Ming</ForeName><Initials>DM</Initials></Author><Author ValidYN="Y"><LastName>Liang</LastName><ForeName>Chun-Chin</ForeName><Initials>CC</Initials></Author><Author ValidYN="Y"><LastName>Lai</LastName><ForeName>Jenn-Haung</ForeName><Initials>JH</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2008</Year><Month>05</Month><Day>06</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Eur J Pharmacol</MedlineTA><NlmUniqueID>1254354</NlmUniqueID><ISSNLinking>0014-2999</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000893">Anti-Inflammatory Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000998">Antiviral Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D044182">Benzylisoquinolines</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004224">Diterpenes</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004852">Epoxy Compounds</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007155">Immunologic Factors</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016328">NF-kappa B</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D010616">Phenanthrenes</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018808">Transcription Factor AP-1</NameOfSubstance></Chemical><Chemical><RegistryNumber>19ALD1S53J</RegistryNumber><NameOfSubstance UI="C001899">triptolide</NameOfSubstance></Chemical><Chemical><RegistryNumber>29EX23D5AJ</RegistryNumber><NameOfSubstance UI="C009438">tetrandrine</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.14.99.1</RegistryNumber><NameOfSubstance UI="D051546">Cyclooxygenase 2</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.14.99.1</RegistryNumber><NameOfSubstance UI="C496540">PTGS2 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>K7Q1JQR04M</RegistryNumber><NameOfSubstance UI="D015232">Dinoprostone</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000893" MajorTopicYN="N">Anti-Inflammatory Agents</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000998" MajorTopicYN="N">Antiviral Agents</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D044182" MajorTopicYN="N">Benzylisoquinolines</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D045744" MajorTopicYN="N">Cell Line, Tumor</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051546" MajorTopicYN="N">Cyclooxygenase 2</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003713" MajorTopicYN="N">Dendritic Cells</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000201" MajorTopicYN="N">enzymology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003716" MajorTopicYN="N">Dengue Virus</DescriptorName><QualifierName UI="Q000254" MajorTopicYN="N">growth &amp; development</QualifierName><QualifierName UI="Q000472" MajorTopicYN="Y">pathogenicity</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015232" MajorTopicYN="N">Dinoprostone</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004224" MajorTopicYN="N">Diterpenes</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004305" MajorTopicYN="N">Dose-Response Relationship, Drug</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004789" MajorTopicYN="N">Enzyme Activation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004852" MajorTopicYN="N">Epoxy Compounds</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007155" MajorTopicYN="N">Immunologic Factors</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008099" MajorTopicYN="N">Liver</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000201" MajorTopicYN="N">enzymology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008168" MajorTopicYN="N">Lung</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName><QualifierName UI="Q000201" MajorTopicYN="N">enzymology</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016328" MajorTopicYN="N">NF-kappa B</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010616" MajorTopicYN="N">Phenanthrenes</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018808" MajorTopicYN="N">Transcription Factor AP-1</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014779" MajorTopicYN="N">Virus Replication</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2007</Year><Month>10</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2008</Year><Month>4</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2008</Year><Month>4</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2008</Year><Month>6</Month><Day>21</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2008</Year><Month>10</Month><Day>25</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2008</Year><Month>6</Month><Day>21</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">18565510</ArticleId><ArticleId IdType="pmc">PMC7094504</ArticleId><ArticleId IdType="doi">10.1016/j.ejphar.2008.04.056</ArticleId><ArticleId IdType="pii">S0014-2999(08)00487-1</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Brinker A.M., Ma J., Lipsky P.E., Raskin I. Medicinal chemistry and pharmacology of genus Tripterygium (Celastraceae) Phytochemistry. 2007;68:732&#x2013;766.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3867260</ArticleId><ArticleId IdType="pubmed">17250858</ArticleId></ArticleIdList></Reference><Reference><Citation>Carey M.A., Bradbury J.A., Seubert J.M., Langenbach R., Zeldin D.C., Germolec D.R. Contrasting effects of cyclooxygenase-1 (COX-1) and COX-2 deficiency on the host response to influenza A viral infection. J. Immunol. 2005;175:6878&#x2013;6884.</Citation><ArticleIdList><ArticleId IdType="pubmed">16272346</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen C.J., Raung S.L., Kuo M.D., Wang Y.M. Suppression of Japanese encephalitis virus infection by non-steroidal anti-inflammatory drugs. J. Gen. Virol. 2002;83:1897&#x2013;1905.</Citation><ArticleIdList><ArticleId IdType="pubmed">12124453</ArticleId></ArticleIdList></Reference><Reference><Citation>Chun K.S., Surh Y.J. Signal transduction pathways regulating cyclooxygenase-2 expression: potential molecular targets for chemoprevention. Biochem. Pharmacol. 2004;68:1089&#x2013;1100.</Citation><ArticleIdList><ArticleId IdType="pubmed">15313405</ArticleId></ArticleIdList></Reference><Reference><Citation>Dai Y.Q., Jin D.Z., Zhu X.Z., Lei D.L. Triptolide inhibits COX-2 expression via NF-kappa B pathway in astrocytes. Neurosci. Res. 2006;55:154&#x2013;160.</Citation><ArticleIdList><ArticleId IdType="pubmed">16600409</ArticleId></ArticleIdList></Reference><Reference><Citation>De Bosscher K., Vanden Berghe W., Haegeman G. The interplay between the glucocorticoid receptor and nuclear factor-kappaB or activator protein-1: molecular mechanisms for gene repression. Endocr. Rev. 2003;24:488&#x2013;522.</Citation><ArticleIdList><ArticleId IdType="pubmed">12920152</ArticleId></ArticleIdList></Reference><Reference><Citation>de Moraes E., Dar N.A., de Moura Gallo C.V., Hainaut P. Cross-talks between cyclooxygenase-2 and tumor suppressor protein p53: balancing life and death during inflammatory stress and carcinogenesis. Int. J. Cancer. 2007;121:929&#x2013;937.</Citation><ArticleIdList><ArticleId IdType="pubmed">17582597</ArticleId></ArticleIdList></Reference><Reference><Citation>Dong Z., Huang C., Brown R.E., Ma W.Y. Inhibition of activator protein 1 activity and neoplastic transformation by aspirin. J. Biol. Chem. 1997;272:9962&#x2013;9970.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4003901</ArticleId><ArticleId IdType="pubmed">9092536</ArticleId></ArticleIdList></Reference><Reference><Citation>Gualde N., Harizi H. Prostanoids and their receptors that modulate dendritic cell-mediated immunity. Immunol. Cell Biol. 2004;82:353&#x2013;360.</Citation><ArticleIdList><ArticleId IdType="pubmed">15283844</ArticleId></ArticleIdList></Reference><Reference><Citation>Herrlich P. Cross-talk between glucocorticoid receptor and AP-1. Oncogene. 2001;20:2465&#x2013;2475.</Citation><ArticleIdList><ArticleId IdType="pubmed">11402341</ArticleId></ArticleIdList></Reference><Reference><Citation>Hiscott J., Nguyen T.L., Arguello M., Nakhaei P., Paz S. Manipulation of the nuclear factor-kappaB pathway and the innate immune response by viruses. Oncogene. 2006;25:6844&#x2013;6867.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7100320</ArticleId><ArticleId IdType="pubmed">17072332</ArticleId></ArticleIdList></Reference><Reference><Citation>Ho L.J., Lai J.H. Chinese herbs as immunomodulators and potential disease-modifying antirheumatic drugs in autoimmune disorders. Curr. Drug Metab. 2004;5:181&#x2013;192.</Citation><ArticleIdList><ArticleId IdType="pubmed">15078195</ArticleId></ArticleIdList></Reference><Reference><Citation>Ho L.J., Chang D.M., Shiau H.Y., Chen C.H., Hsieh T.Y., Hsu Y.L., Wong C.S., Lai J.H. Aspirin differentially regulates endotoxin-induced IL-12 and TNF-alpha production in human dendritic cells. Scand. J. Rheumatol. 2001;30:346&#x2013;352.</Citation><ArticleIdList><ArticleId IdType="pubmed">11846053</ArticleId></ArticleIdList></Reference><Reference><Citation>Ho L.J., Wang J.J., Shaio M.F., Kao C.L., Chang D.M., Han S.W., Lai J.H. Infection of human dendritic cells by dengue virus causes cell maturation and cytokine production. J. Immunol. 2001;166:1499&#x2013;1506.</Citation><ArticleIdList><ArticleId IdType="pubmed">11160189</ArticleId></ArticleIdList></Reference><Reference><Citation>Ho L.J., Juan T.Y., Chao P., Wu W.L., Chang D.M., Chang S.Y., Lai J.H. Plant alkaloid tetrandrine downregulates IkappaBalpha kinases-IkappaBalpha-NF-kappaB signaling pathway in human peripheral blood T cell. Br. J. Pharmacol. 2004;143:919&#x2013;927.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1575940</ArticleId><ArticleId IdType="pubmed">15504755</ArticleId></ArticleIdList></Reference><Reference><Citation>Ho L.J., Hung L.F., Weng C.Y., Wu W.L., Chou P., Lin Y.L., Chang D.M., Tai T.Y., Lai J.H. Dengue virus type 2 antagonizes IFN-alpha but not IFN-gamma antiviral effect via down-regulating Tyk2-STAT signaling in the human dendritic cell. J. Immunol. 2005;174:8163&#x2013;8172.</Citation><ArticleIdList><ArticleId IdType="pubmed">15944325</ArticleId></ArticleIdList></Reference><Reference><Citation>Hooks J.J., Chin M.S., Srinivasan K., Momma Y., Hooper L.C., Nagineni C.N., Chan C.C., Detrick B. Human cytomegalovirus induced cyclooxygenase-2 in human retinal pigment epithelial cells augments viral replication through a prostaglandin pathway. Microbes Infect. 2006;8:2236&#x2013;2244.</Citation><ArticleIdList><ArticleId IdType="pubmed">16782382</ArticleId></ArticleIdList></Reference><Reference><Citation>Iniguez M.A., Martinez-Martinez S., Punzon C., Redondo J.M., Fresno M. An essential role of the nuclear factor of activated T cells in the regulation of the expression of the cyclooxygenase-2 gene in human T lymphocytes. J. Biol. Chem. 2000;275:23627&#x2013;23635.</Citation><ArticleIdList><ArticleId IdType="pubmed">10816557</ArticleId></ArticleIdList></Reference><Reference><Citation>Jassim S.A., Naji M.A. Novel antiviral agents: a medicinal plant perspective. J. Appl. Microbiol. 2003;95:412&#x2013;427.</Citation><ArticleIdList><ArticleId IdType="pubmed">12911688</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang X.H., Wong B.C., Lin M.C., Zhu G.H., Kung H.F., Jiang S.H., Yang D., Lam S.K. Functional p53 is required for triptolide-induced apoptosis and AP-1 and nuclear factor-kappaB activation in gastric cancer cells. Oncogene. 2001;20:8009&#x2013;8018.</Citation><ArticleIdList><ArticleId IdType="pubmed">11753684</ArticleId></ArticleIdList></Reference><Reference><Citation>Karin M., Liu Z., Zandi E. AP-1 function and regulation. Curr. Opin. Cell Biol. 1997;9:240&#x2013;246.</Citation><ArticleIdList><ArticleId IdType="pubmed">9069263</ArticleId></ArticleIdList></Reference><Reference><Citation>Khyatti M., Menezes J. The effect of indomethacin, prostaglandin E2 and interferon on the multiplication of herpes simplex virus type 1 in human lymphoid cells. Antivir. Res. 1990;14:161&#x2013;172.</Citation><ArticleIdList><ArticleId IdType="pubmed">1964373</ArticleId></ArticleIdList></Reference><Reference><Citation>Kopp E., Ghosh S. Inhibition of NF-kappa B by sodium salicylate and aspirin. Science. 1994;265:956&#x2013;959.</Citation><ArticleIdList><ArticleId IdType="pubmed">8052854</ArticleId></ArticleIdList></Reference><Reference><Citation>Krakauer T., Chen X., Howard O.M., Young H.A. Triptolide attenuates endotoxin- and staphylococcal exotoxin-induced T-cell proliferation and production of cytokines and chemokines. Immunopharmacol. Immunotoxicol. 2005;27:53&#x2013;66.</Citation><ArticleIdList><ArticleId IdType="pubmed">15803859</ArticleId></ArticleIdList></Reference><Reference><Citation>Lai J.H., Ho L.J., Kwan C.Y., Chang D.M., Lee T.C. Plant alkaloid tetrandrine and its analog block CD28-costimulated activities of human peripheral blood T cells: potential immunosuppressants in transplantation immunology. Transplantation. 1999;68:1383&#x2013;1392.</Citation><ArticleIdList><ArticleId IdType="pubmed">10573080</ArticleId></ArticleIdList></Reference><Reference><Citation>Lai J.H., Ho L.J., Lu K.C., Chang D.M., Shaio M.F., Han S.H. Western and Chinese antirheumatic drug-induced T cell apoptotic DNA damage uses different caspase cascades and is independent of Fas/Fas ligand interaction. J. Immunol. 2001;166:6914&#x2013;6924.</Citation><ArticleIdList><ArticleId IdType="pubmed">11359853</ArticleId></ArticleIdList></Reference><Reference><Citation>Lara-Pezzi E., Gomez-Gaviro M.V., Galvez B.G., Mira E., Iniguez M.A., Fresno M., Martinez A.C., Arroyo A.G., Lopez-Cabrera M. The hepatitis B virus X protein promotes tumor cell invasion by inducing membrane-type matrix metalloproteinase-1 and cyclooxygenase-2 expression. J. Clin. Invest. 2002;110:1831&#x2013;1838.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC151651</ArticleId><ArticleId IdType="pubmed">12488433</ArticleId></ArticleIdList></Reference><Reference><Citation>Lawrence T., Willoughby D.A., Gilroy D.W. Anti-inflammatory lipid mediators and insights into the resolution of inflammation. Nat. Rev., Immunol. 2002;2:787&#x2013;795.</Citation><ArticleIdList><ArticleId IdType="pubmed">12360216</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee Y.R., Su C.Y., Chow N.H., Lai W.W., Lei H.Y., Chang C.L., Chang T.Y., Chen S.H., Lin Y.S., Yeh T.M., Liu H.S. Dengue viruses can infect human primary lung epithelia as well as lung carcinoma cells, and can also induce the secretion of IL-6 and RANTES. Virus Res. 2007;126:216&#x2013;225.</Citation><ArticleIdList><ArticleId IdType="pubmed">17416433</ArticleId></ArticleIdList></Reference><Reference><Citation>Liao C.L., Lin Y.L., Wu B.C., Tsao C.H., Wang M.C., Liu C.I., Huang Y.L., Chen J.H., Wang J.P., Chen L.K. Salicylates inhibit flavivirus replication independently of blocking nuclear factor kappa B activation. J. Virol. 2001;75:7828&#x2013;7839.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC115025</ArticleId><ArticleId IdType="pubmed">11483726</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin C.F., Wan S.W., Cheng H.J., Lei H.Y., Lin Y.S. Autoimmune pathogenesis in dengue virus infection. Viral Immunol. 2006;19:127&#x2013;132.</Citation><ArticleIdList><ArticleId IdType="pubmed">16817755</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu T., Zaman W., Kaphalia B.S., Ansari G.A., Garofalo R.P., Casola A. RSV-induced prostaglandin E2 production occurs via cPLA2 activation: role in viral replication. Virology. 2005;343:12&#x2013;24.</Citation><ArticleIdList><ArticleId IdType="pubmed">16153673</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Q., Chen T., Chen G., Li N., Wang J., Ma P., Cao X. Immunosuppressant triptolide inhibits dendritic cell-mediated chemoattraction of neutrophils and T cells through inhibiting Stat3 phosphorylation and NF-kappaB activation. Biochem. Biophys. Res. Commun. 2006;345:1122&#x2013;1130.</Citation><ArticleIdList><ArticleId IdType="pubmed">16713992</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Q., Chen T., Chen G., Shu X., Sun A., Ma P., Lu L., Cao X. Triptolide impairs dendritic cell migration by inhibiting CCR7 and COX-2 expression through PI3-K/Akt and NF-kappaB pathways. Mol. Immunol. 2007;44:2686&#x2013;2696.</Citation><ArticleIdList><ArticleId IdType="pubmed">17223196</ArticleId></ArticleIdList></Reference><Reference><Citation>Marcet B., Libert F., Boeynaems J.M., Communi D. Extracellular nucleotides induce COX-2 up-regulation and prostaglandin E2 production in human A549 alveolar type II epithelial cells. Eur. J. Pharmacol. 2007;566:167&#x2013;171.</Citation><ArticleIdList><ArticleId IdType="pubmed">17481603</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin K.W., Ernst E. Antiviral agents from plants and herbs: a systematic review. Antivir. Ther. 2003;8:77&#x2013;90.</Citation><ArticleIdList><ArticleId IdType="pubmed">12741619</ArticleId></ArticleIdList></Reference><Reference><Citation>Moriuchi M., Inoue H., Moriuchi H. Reciprocal interactions between human T-lymphotropic virus type 1 and prostaglandins: implications for viral transmission. J. Virol. 2001;75:192&#x2013;198.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC113912</ArticleId><ArticleId IdType="pubmed">11119588</ArticleId></ArticleIdList></Reference><Reference><Citation>Pang L., Hoult J.R. Cytotoxicity to macrophages of tetrandrine, an antisilicosis alkaloid, accompanied by an overproduction of prostaglandins. Biochem. Pharmacol. 1997;53:773&#x2013;782.</Citation><ArticleIdList><ArticleId IdType="pubmed">9113098</ArticleId></ArticleIdList></Reference><Reference><Citation>Park G.Y., Christman J.W. Involvement of cyclooxygenase-2 and prostaglandins in the molecular pathogenesis of inflammatory lung diseases. Am. J. Physiol., Lung Cell. Mol. Physiol. 2006;290:L797&#x2013;L805.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4358817</ArticleId><ArticleId IdType="pubmed">16603593</ArticleId></ArticleIdList></Reference><Reference><Citation>Phipps R.P., Stein S.H., Roper R.L. A new view of prostaglandin E regulation of the immune response. Immunol. Today. 1991;12:349&#x2013;352.</Citation><ArticleIdList><ArticleId IdType="pubmed">1958288</ArticleId></ArticleIdList></Reference><Reference><Citation>Primache V., Binda S., De Benedittis G., Barbi M. In vitro activity of acetylsalicylic acid on replication of varicella-zoster virus. New Microbiol. 1998;21:397&#x2013;401.</Citation><ArticleIdList><ArticleId IdType="pubmed">9812322</ArticleId></ArticleIdList></Reference><Reference><Citation>Qiu D., Zhao G., Aoki Y., Shi L., Uyei A., Nazarian S., Ng J.C., Kao P.N. Immunosuppressant PG490 (triptolide) inhibits T-cell interleukin-2 expression at the level of purine-box/nuclear factor of activated T-cells and NF-kappaB transcriptional activation. J. Biol. Chem. 1999;274:13443&#x2013;13450.</Citation><ArticleIdList><ArticleId IdType="pubmed">10224109</ArticleId></ArticleIdList></Reference><Reference><Citation>Raaben M., Einerhand A.W., Taminiau L.J., van Houdt M., Bouma J., Raatgeep R.H., Buller H.A., de Haan C.A., Rossen J.W. Cyclooxygenase activity is important for efficient replication of mouse hepatitis virus at an early stage of infection. Virol. J. 2007;4:55.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1892777</ArticleId><ArticleId IdType="pubmed">17555580</ArticleId></ArticleIdList></Reference><Reference><Citation>Ray N., Bisher M.E., Enquist L.W. Cyclooxygenase-1 and -2 are required for production of infectious pseudorabies virus. J. Virol. 2004;78:12964&#x2013;12974.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC525029</ArticleId><ArticleId IdType="pubmed">15542648</ArticleId></ArticleIdList></Reference><Reference><Citation>Reynolds A.E., Enquist L.W. Biological interactions between herpesviruses and cyclooxygenase enzymes. Rev. Med. Virol. 2006;16:393&#x2013;403.</Citation><ArticleIdList><ArticleId IdType="pubmed">17006962</ArticleId></ArticleIdList></Reference><Reference><Citation>Richardson J.Y., Ottolini M.G., Pletneva L., Boukhvalova M., Zhang S., Vogel S.N., Prince G.A., Blanco J.C. Respiratory syncytial virus (RSV) infection induces cyclooxygenase 2: a potential target for RSV therapy. J. Immunol. 2005;174:4356&#x2013;4364.</Citation><ArticleIdList><ArticleId IdType="pubmed">15778400</ArticleId></ArticleIdList></Reference><Reference><Citation>Rocca B., FitzGerald G.A. Cyclooxygenases and prostaglandins: shaping up the immune response. Int. Immunopharmacol. 2002;2:603&#x2013;630.</Citation><ArticleIdList><ArticleId IdType="pubmed">12013502</ArticleId></ArticleIdList></Reference><Reference><Citation>Rossen J.W., Bouma J., Raatgeep R.H., Buller H.A., Einerhand A.W. Inhibition of cyclooxygenase activity reduces rotavirus infection at a postbinding step. J. Virol. 2004;78:9721&#x2013;9730.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC514972</ArticleId><ArticleId IdType="pubmed">15331705</ArticleId></ArticleIdList></Reference><Reference><Citation>Sadowska B., Barrucco R., Khalili K., Safak M. Regulation of human polyomavirus JC virus gene transcription by AP-1 in glial cells. J. Virol. 2003;77:665&#x2013;672.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC140566</ArticleId><ArticleId IdType="pubmed">12477869</ArticleId></ArticleIdList></Reference><Reference><Citation>Santoro M.G., Rossi A., Amici C. NF-kappaB and virus infection: who controls whom. EMBO J. 2003;22:2552&#x2013;2560.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC156764</ArticleId><ArticleId IdType="pubmed">12773372</ArticleId></ArticleIdList></Reference><Reference><Citation>Sarkar F.H., Adsule S., Li Y., Padhye S. Back to the future: COX-2 inhibitors for chemoprevention and cancer therapy. Mini Rev. Med. Chem. 2007;7:599&#x2013;608.</Citation><ArticleIdList><ArticleId IdType="pubmed">17584158</ArticleId></ArticleIdList></Reference><Reference><Citation>Savard M., Belanger C., Tremblay M.J., Dumais N., Flamand L., Borgeat P., Gosselin J. EBV suppresses prostaglandin E2 biosynthesis in human monocytes. J. Immunol. 2000;164:6467&#x2013;6473.</Citation><ArticleIdList><ArticleId IdType="pubmed">10843703</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma-Walia N., Raghu H., Sadagopan S., Sivakumar R., Veettil M.V., Naranatt P.P., Smith M.M., Chandran B. Cyclooxygenase 2 induced by Kaposi's sarcoma-associated herpesvirus early during in vitro infection of target cells plays a role in the maintenance of latent viral gene expression. J. Virol. 2006;80:6534&#x2013;6552.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1488986</ArticleId><ArticleId IdType="pubmed">16775340</ArticleId></ArticleIdList></Reference><Reference><Citation>Speir E., Yu Z.X., Ferrans V.J., Huang E.S., Epstein S.E. Aspirin attenuates cytomegalovirus infectivity and gene expression mediated by cyclooxygenase-2 in coronary artery smooth muscle cells. Circ. Res. 1998;83:210&#x2013;216.</Citation><ArticleIdList><ArticleId IdType="pubmed">9686761</ArticleId></ArticleIdList></Reference><Reference><Citation>Steer S.A., Corbett J.A. The role and regulation of COX-2 during viral infection. Viral Immunol. 2003;16:447&#x2013;460.</Citation><ArticleIdList><ArticleId IdType="pubmed">14733733</ArticleId></ArticleIdList></Reference><Reference><Citation>Tao X., Schulze-Koops H., Ma L., Cai J., Mao Y., Lipsky P.E. Effects of Tripterygium wilfordii hook F extracts on induction of cyclooxygenase 2 activity and prostaglandin E2 production. Arthritis Rheum. 1998;41:130&#x2013;138.</Citation><ArticleIdList><ArticleId IdType="pubmed">9433878</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsatsanis C., Androulidaki A., Venihaki M., Margioris A.N. Signalling networks regulating cyclooxygenase-2. Int. J. Biochem. Cell Biol. 2006;38:1654&#x2013;1661.</Citation><ArticleIdList><ArticleId IdType="pubmed">16713323</ArticleId></ArticleIdList></Reference><Reference><Citation>Wachsman M., Aurelian L., Burnett J.W. The prophylactic use of cyclooxygenase inhibitors in recurrent herpes simplex infections. Br. J. Dermatol. 1990;123:375&#x2013;380.</Citation><ArticleIdList><ArticleId IdType="pubmed">2119789</ArticleId></ArticleIdList></Reference><Reference><Citation>Waris G., Siddiqui A. Hepatitis C virus stimulates the expression of cyclooxygenase-2 via oxidative stress: role of prostaglandin E2 in RNA replication. J. Virol. 2005;79:9725&#x2013;9734.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1181604</ArticleId><ArticleId IdType="pubmed">16014934</ArticleId></ArticleIdList></Reference><Reference><Citation>Watkins D.N., Peroni D.J., Lenzo J.C., Knight D.A., Garlepp M.J., Thompson P.J. Expression and localization of COX-2 in human airways and cultured airway epithelial cells. Eur. Respir. J. 1999;13:999&#x2013;1007.</Citation><ArticleIdList><ArticleId IdType="pubmed">10414396</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams C.S., Mann M., DuBois R.N. The role of cyclooxygenases in inflammation, cancer, and development. Oncogene. 1999;18:7908&#x2013;7916.</Citation><ArticleIdList><ArticleId IdType="pubmed">10630643</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu S.J., Ng L.T. Tetrandrine inhibits proinflammatory cytokines, iNOS and COX-2 expression in human monocytic cells. Biol. Pharm. Bull. 2007;30:59&#x2013;62.</Citation><ArticleIdList><ArticleId IdType="pubmed">17202660</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang S.P., Ho L.J., Lin Y.L., Cheng S.M., Tsao T.P., Chang D.M., Hsu Y.L., Shih C.Y., Juan T.Y., Lai J.H. Carvedilol, a new antioxidative beta-blocker, blocks in vitro human peripheral blood T cell activation by downregulating NF-kappaB activity. Cardiovasc. Res. 2003;59:776&#x2013;787.</Citation><ArticleIdList><ArticleId IdType="pubmed">14499879</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang H., Li Y.Y., Wu X.Z. Effect of tetrandrine on LPS-induced NF-kappaB activation in isolated pancreatic acinar cells of rat. World J. Gastroenterol. 2006;12:4232&#x2013;4236.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4087381</ArticleId><ArticleId IdType="pubmed">16830382</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhong B., Tien P., Shu H.B. Innate immune responses: crosstalk of signaling and regulation of gene transcription. Virology. 2006;352:14&#x2013;21.</Citation><ArticleIdList><ArticleId IdType="pubmed">16753195</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>